EGFR inhibitors in NSCLC and the role of biomarkers for selection of patients

Published on January 6, 2009 Archived on June 22, 2016   36 min

Other Talks in the Therapeutic Area: Oncology

Hide

EGFR inhibitors in NSCLC and the role of biomarkers for selection of patients

Embed in course/own notes